This role serves as a flexible program leader within the Separation Management Office (SMO), supporting the successful separation of Medtronic’s Diabetes business by driving critical operational priorities across Order-to-Cash, Procure-to-pay, Transition Services Agreement (TSA) exits, and delayed market readiness.
Base: $115,200.00 - $172,800.00; Bonus/Equity: Eligible for Medtronic Incentive Plan (MIP); Benefits: Health, Dental, Vision, 401k match, PTO, etc.
Must-have
Nice-to-have
Must possess unrestricted U.S. work authorization